Aju Ib Investment Co., Ltd. Apellis Pharmaceuticals, Inc. Transaction History

Aju Ib Investment Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$30.74 - $49.16 $19.2 Million - $30.7 Million	-624,962 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$31.4 - $69.84 $13.8 Million - $30.7 Million	-440,000 Reduced 41.32%	624,962 $20.6 Million
Q2 2021 Aug 10, 2021	SELL	$40.9 - $64.9 $2.05 Million - $3.25 Million	-50,000 Reduced 4.48%	1,064,962 $67.3 Million
Q4 2020 May 12, 2021	BUY	$30.79 - $57.2 $34.3 Million - $63.8 Million	1,114,962 New	1,114,962 $63.8 Million

308

115M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Aju Ib Investment Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Aju Ib Investment Co., Ltd. with notifications on news.